ECOG 0 4 0 4 B-clinical_variable
( 5 6 5 6 I-clinical_variable
Eastern 6 13 6 13 I-clinical_variable
Cooperative 14 25 14 25 I-clinical_variable
Oncology 26 34 26 34 I-clinical_variable
Group 35 40 35 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
â‰¤1 61 63 61 63 O

ER 0 2 64 66 B-clinical_variable
( 3 4 67 68 I-clinical_variable
estrogen 4 12 68 76 I-clinical_variable
receptors 13 22 77 86 I-clinical_variable
) 22 23 86 87 I-clinical_variable
and 24 27 88 91 O
PR 28 30 92 94 B-clinical_variable
( 31 32 95 96 I-clinical_variable
progesterone 32 44 96 108 I-clinical_variable
receptors 45 54 109 118 I-clinical_variable
) 54 55 118 119 I-clinical_variable
expression 56 66 120 130 O
must 67 71 131 135 O
be 72 74 136 138 O
< 75 76 139 140 O
2 77 78 141 142 B-upper_bound
% 78 79 142 143 I-upper_bound

HER2 0 4 144 148 B-clinical_variable
must 5 9 149 153 O
negative 10 18 154 162 O
as 19 21 163 165 O
shown 22 27 166 171 O
be 28 30 172 174 O
either 31 37 175 181 O
0 38 39 182 183 B-lower_bound
or 40 42 184 186 O
1 43 44 187 188 B-upper_bound
+ 44 45 188 189 I-upper_bound
by 46 48 190 192 O
immunohistochemistry 49 69 193 213 O
( 70 71 214 215 O
if 71 73 215 217 O
2 74 75 218 219 O
+ 75 76 219 220 O
, 76 77 220 221 O
in 78 80 222 224 O
situ 81 85 225 229 O
hybridization 86 99 230 243 O
method 100 106 244 250 O
used 107 111 251 255 O
to 112 114 256 258 O
define 115 121 259 265 O
HER2 122 126 266 270 O
) 126 127 270 271 O
OR 128 130 272 274 O
by 131 133 275 277 O
a 134 135 278 279 O
HER2 136 140 280 284 O
: 140 141 284 285 O
17 142 144 286 288 O
centromere 145 155 289 299 B-clinical_variable
signal 156 162 300 306 I-clinical_variable
of 163 165 307 309 O
< 166 167 310 311 O
2.0 167 170 311 314 B-upper_bound
using 171 176 315 320 O
a 177 178 321 322 O
standard 179 187 323 331 O
in 188 190 332 334 O
situ 191 195 335 339 O
hybridization 196 209 340 353 O
method 210 216 354 360 O

No 0 2 361 363 O
prior 3 8 364 369 B-treatment
therapy 9 16 370 377 I-treatment
for 17 20 378 381 O
current 21 28 382 389 O
breast 29 35 390 396 B-cancer
cancer 36 42 397 403 I-cancer

Non 0 3 404 407 B-pregnancy
- 3 4 407 408 I-pregnancy
pregnant 4 12 408 416 I-pregnancy

Operable 0 8 417 425 O
breast 9 15 426 432 B-chronic_disease
cancer 16 22 433 439 I-chronic_disease

Participants 0 12 440 452 O
must 13 17 453 457 O
have 18 22 458 462 O
histologically 23 37 463 477 O
confirmed 38 47 478 487 O
operable 48 56 488 496 O
triple 57 63 497 503 B-chronic_disease
negative 64 72 504 512 I-chronic_disease
breast 73 79 513 519 I-chronic_disease
cancer 80 86 520 526 I-chronic_disease

Participants 0 12 527 539 O
who 13 16 540 543 O
are 17 20 544 547 O
planned 21 28 548 555 O
to 29 31 556 558 O
undergo 32 39 559 566 O
neo 40 43 567 570 B-treatment
- 43 44 570 571 I-treatment
adjuvant 44 52 571 579 I-treatment
chemotherapy 53 65 580 592 I-treatment
are 66 69 593 596 O
eligible 70 78 597 605 O
as 79 81 606 608 O
long 82 86 609 613 O
as 87 89 614 616 O
they 90 94 617 621 O
consent 95 102 622 629 O
to 103 105 630 632 O
an 106 108 633 635 O
additional 109 119 636 646 O
breast 120 126 647 653 B-treatment
biopsy 127 133 654 660 I-treatment
following 134 143 661 670 O
the 144 147 671 674 O
dietary 148 155 675 682 O
intervention 156 168 683 695 O
immediately 169 180 696 707 O
prior 181 186 708 713 O
to 187 189 714 716 O
starting 190 198 717 725 O
chemotherapy 199 211 726 738 O

Patients 0 8 739 747 O
not 9 12 748 751 O
able 13 17 752 756 O
to 18 20 757 759 O
swallow 21 28 760 767 O
oral 29 33 768 772 O
medications 34 45 773 784 O
or 46 48 785 787 O
with 49 53 788 792 O
gastrointestinal 54 70 793 809 B-chronic_disease
conditions 71 81 810 820 I-chronic_disease
that 82 86 821 825 O
may 87 90 826 829 O
impact 91 97 830 836 O
absorption 98 108 837 847 O
of 109 111 848 850 O
oral 112 116 851 855 O
medications 117 128 856 867 O

Uncontrolled 0 12 868 880 O
intercurrent 13 25 881 893 O
illness 26 33 894 901 O
including 34 43 902 911 O
, 43 44 911 912 O
but 45 48 913 916 O
not 49 52 917 920 O
limited 53 60 921 928 O
to 61 63 929 931 O
, 63 64 931 932 O
ongoing 65 72 933 940 O
or 73 75 941 943 O
active 76 82 944 950 B-chronic_disease
infection 83 92 951 960 I-chronic_disease
, 92 93 960 961 O
symptomatic 94 105 962 973 O
congestive 106 116 974 984 B-chronic_disease
heart 117 122 985 990 I-chronic_disease
failure 123 130 991 998 I-chronic_disease
, 130 131 998 999 O
unstable 132 140 1000 1008 B-chronic_disease
angina 141 147 1009 1015 I-chronic_disease
pectoris 148 156 1016 1024 I-chronic_disease
, 156 157 1024 1025 O
cardiac 158 165 1026 1033 B-chronic_disease
arrhythmia 166 176 1034 1044 I-chronic_disease
, 176 177 1044 1045 O
or 178 180 1046 1048 O
psychiatric 181 192 1049 1060 B-chronic_disease
illness 193 200 1061 1068 I-chronic_disease
/ 200 201 1068 1069 O
social 201 207 1069 1075 O
situations 208 218 1076 1086 O
that 219 223 1087 1091 O
would 224 229 1092 1097 O
limit 230 235 1098 1103 O
compliance 236 246 1104 1114 O
with 247 251 1115 1119 O
study 252 257 1120 1125 O
requirements 258 270 1126 1138 O

Women 0 5 1139 1144 B-gender
of 6 8 1145 1147 O
childbearing 9 21 1148 1160 O
potential 22 31 1161 1170 O
must 32 36 1171 1175 O
agree 37 42 1176 1181 B-contraception_consent
to 43 45 1182 1184 I-contraception_consent
use 46 49 1185 1188 I-contraception_consent
effective 50 59 1189 1198 I-contraception_consent
contraceptives 60 74 1199 1213 I-contraception_consent
( 75 76 1214 1215 O
as 76 78 1215 1217 O
discussed 79 88 1218 1227 O
with 89 93 1228 1232 O
their 94 99 1233 1238 O
physician 100 109 1239 1248 O
) 109 110 1248 1249 O
while 111 116 1250 1255 O
participating 117 130 1256 1269 O
in 131 133 1270 1272 O
this 134 138 1273 1277 O
study 139 144 1278 1283 O

Women 0 5 1284 1289 B-gender
of 6 8 1290 1292 O
childbearing 9 21 1293 1305 O
potential 22 31 1306 1315 O
must 32 36 1316 1320 O
have 37 41 1321 1325 O
a 42 43 1326 1327 O
negative 44 52 1328 1336 B-pregnancy
pregnancy 53 62 1337 1346 I-pregnancy
test 63 67 1347 1351 O
to 68 70 1352 1354 O
participate 71 82 1355 1366 O
in 83 85 1367 1369 O
this 86 90 1370 1374 O
study 91 96 1375 1380 O

